Cargando…

Stability data of extemporaneous oral suspension of pentobarbital in Syrspend SF Alka for imaging sedation procedure

Pentobarbital is used as an alternative in pediatric sedative imaging procedures. Pentobarbital is only available as pharmaceutical powder. Regardless of its clinical use, its manipulation is necessary byhospital pharmacists that must prepare adapted dosage forms for pediatrics. The data presented i...

Descripción completa

Detalles Bibliográficos
Autores principales: Querin, Benjamin, Schweitzer-Chaput, Arnaud, Nedjar, Chahrazed, Schlatter, Joël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910507/
https://www.ncbi.nlm.nih.gov/pubmed/33681434
http://dx.doi.org/10.1016/j.dib.2021.106884
_version_ 1783656132846288896
author Querin, Benjamin
Schweitzer-Chaput, Arnaud
Nedjar, Chahrazed
Schlatter, Joël
author_facet Querin, Benjamin
Schweitzer-Chaput, Arnaud
Nedjar, Chahrazed
Schlatter, Joël
author_sort Querin, Benjamin
collection PubMed
description Pentobarbital is used as an alternative in pediatric sedative imaging procedures. Pentobarbital is only available as pharmaceutical powder. Regardless of its clinical use, its manipulation is necessary byhospital pharmacists that must prepare adapted dosage forms for pediatrics. The data presented in this article suggest that extemporaneous suspensions of sodium pentobarbital in oral liquid base are stable for at least 120 days.
format Online
Article
Text
id pubmed-7910507
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-79105072021-03-04 Stability data of extemporaneous oral suspension of pentobarbital in Syrspend SF Alka for imaging sedation procedure Querin, Benjamin Schweitzer-Chaput, Arnaud Nedjar, Chahrazed Schlatter, Joël Data Brief Data Article Pentobarbital is used as an alternative in pediatric sedative imaging procedures. Pentobarbital is only available as pharmaceutical powder. Regardless of its clinical use, its manipulation is necessary byhospital pharmacists that must prepare adapted dosage forms for pediatrics. The data presented in this article suggest that extemporaneous suspensions of sodium pentobarbital in oral liquid base are stable for at least 120 days. Elsevier 2021-02-17 /pmc/articles/PMC7910507/ /pubmed/33681434 http://dx.doi.org/10.1016/j.dib.2021.106884 Text en © 2021 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Data Article
Querin, Benjamin
Schweitzer-Chaput, Arnaud
Nedjar, Chahrazed
Schlatter, Joël
Stability data of extemporaneous oral suspension of pentobarbital in Syrspend SF Alka for imaging sedation procedure
title Stability data of extemporaneous oral suspension of pentobarbital in Syrspend SF Alka for imaging sedation procedure
title_full Stability data of extemporaneous oral suspension of pentobarbital in Syrspend SF Alka for imaging sedation procedure
title_fullStr Stability data of extemporaneous oral suspension of pentobarbital in Syrspend SF Alka for imaging sedation procedure
title_full_unstemmed Stability data of extemporaneous oral suspension of pentobarbital in Syrspend SF Alka for imaging sedation procedure
title_short Stability data of extemporaneous oral suspension of pentobarbital in Syrspend SF Alka for imaging sedation procedure
title_sort stability data of extemporaneous oral suspension of pentobarbital in syrspend sf alka for imaging sedation procedure
topic Data Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910507/
https://www.ncbi.nlm.nih.gov/pubmed/33681434
http://dx.doi.org/10.1016/j.dib.2021.106884
work_keys_str_mv AT querinbenjamin stabilitydataofextemporaneousoralsuspensionofpentobarbitalinsyrspendsfalkaforimagingsedationprocedure
AT schweitzerchaputarnaud stabilitydataofextemporaneousoralsuspensionofpentobarbitalinsyrspendsfalkaforimagingsedationprocedure
AT nedjarchahrazed stabilitydataofextemporaneousoralsuspensionofpentobarbitalinsyrspendsfalkaforimagingsedationprocedure
AT schlatterjoel stabilitydataofextemporaneousoralsuspensionofpentobarbitalinsyrspendsfalkaforimagingsedationprocedure